Clinical trial
A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels
NCT00489541 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUS® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2007
- Completion date
- October 31, 2013
- Enrollment
- 224 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.